Sequoia Financial Advisors LLC Makes New $330,000 Investment in Exponent, Inc. $EXPO

Sequoia Financial Advisors LLC purchased a new position in Exponent, Inc. (NASDAQ:EXPO) during the second quarter, HoldingsChannel.com reports. The fund purchased 4,423 shares of the business services provider’s stock, valued at approximately $330,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Brooklyn Investment Group lifted its holdings in shares of Exponent by 10,200.0% in the first quarter. Brooklyn Investment Group now owns 309 shares of the business services provider’s stock worth $25,000 after buying an additional 306 shares in the last quarter. Bessemer Group Inc. raised its stake in Exponent by 103.3% in the first quarter. Bessemer Group Inc. now owns 681 shares of the business services provider’s stock valued at $55,000 after purchasing an additional 346 shares in the last quarter. SVB Wealth LLC purchased a new stake in Exponent in the first quarter valued at approximately $80,000. Caitong International Asset Management Co. Ltd raised its stake in Exponent by 8,092.9% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,147 shares of the business services provider’s stock valued at $93,000 after purchasing an additional 1,133 shares in the last quarter. Finally, Covestor Ltd raised its stake in Exponent by 43.7% in the first quarter. Covestor Ltd now owns 1,785 shares of the business services provider’s stock valued at $145,000 after purchasing an additional 543 shares in the last quarter. 92.37% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, VP Joseph Sala sold 1,595 shares of Exponent stock in a transaction dated Tuesday, August 12th. The stock was sold at an average price of $70.64, for a total value of $112,670.80. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Catherine Corrigan sold 4,930 shares of Exponent stock in a transaction dated Wednesday, October 15th. The stock was sold at an average price of $66.82, for a total value of $329,422.60. Following the completion of the transaction, the chief executive officer directly owned 82,753 shares of the company’s stock, valued at approximately $5,529,555.46. This represents a 5.62% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 16,326 shares of company stock valued at $1,133,059. 1.60% of the stock is owned by insiders.

Exponent Stock Performance

Shares of Exponent stock opened at $69.92 on Wednesday. The stock has a market capitalization of $3.53 billion, a price-to-earnings ratio of 34.96 and a beta of 0.91. The company’s 50 day moving average price is $69.54 and its 200-day moving average price is $73.64. Exponent, Inc. has a 52-week low of $63.81 and a 52-week high of $112.75.

Exponent (NASDAQ:EXPO) last released its quarterly earnings results on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.04. The business had revenue of $132.87 million for the quarter, compared to analysts’ expectations of $130.82 million. Exponent had a net margin of 18.35% and a return on equity of 24.19%. The firm’s revenue for the quarter was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.57 earnings per share. As a group, equities research analysts forecast that Exponent, Inc. will post 1.98 earnings per share for the current fiscal year.

Exponent Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 19th. Shareholders of record on Friday, September 5th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Friday, September 5th. This represents a $1.20 annualized dividend and a yield of 1.7%. Exponent’s dividend payout ratio (DPR) is currently 60.00%.

Wall Street Analyst Weigh In

Separately, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Exponent in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, Exponent currently has a consensus rating of “Hold”.

Exponent Profile

Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.